Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Morphological and functional evaluation of the left ventricle in severe aortic stenosis with afterload mismatch: a South African single-centre, cross-sectional cardiovascular MRI-based study.

BMJ open·2026
Same author

Serum vs. tissue cytokine dysregulation in SLE-associated myocarditis: a hypothesis from an African cohort perspective.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Evaluation of the Haemodynamic Behaviour of Stenosed Aortic Heart Valves Using Fluid Structure Interaction Modelling.

International journal for numerical methods in biomedical engineering·2026
Same author

Challenges of Infective Endocarditis in South Africa, a Low- to Middle-Income Country.

The Canadian journal of cardiology·2025
Same author

<i>Bartonella</i> endocarditis: a complex diagnosis of blood culture-negative endocarditis in an endemic region of Africa.

Open heart·2025
Same author

Utility of Serum Biomarkers of Myocardial Fibrosis in High-Gradient Severe Aortic Stenosis: An Explorative Cardiovascular Magnetic Resonance Imaging-Based Study.

Diagnostics (Basel, Switzerland)·2025

Video Experimental Relacionado

Updated: Jul 10, 2026

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

La pericarditis tuberculosa también es conocida como pericarditis tuberculosa.

Bongani M Mayosi1, Lesley J Burgess, Anton F Doubell

  • 1The Cardiac Clinic, Department of Medicine, University of Cape Town, Groote Schuur Hospital, Cape Town, South Africa. bmayosi@uctgsh1.uct.ac.za

Circulation
|December 7, 2005
PubMed
Resumen

La pericarditis tuberculosa, relacionada con el VIH, requiere un régimen de 6 meses y 4 medicamentos. Se necesita más investigación para mejorar el diagnóstico y la eficacia del tratamiento, especialmente con respecto a los esteroides y el impacto del VIH.

Más Videos Relacionados

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy
06:49

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy

Published on: May 31, 2017

Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

Videos de Experimentos Relacionados

Last Updated: Jul 10, 2026

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers
13:10

In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers

Published on: August 1, 2014

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy
06:49

Quantitative Visualization of Leukocyte Infiltrate in a Murine Model of Fulminant Myocarditis by Light Sheet Microscopy

Published on: May 31, 2017

Isolation and Identification of Extravascular Immune Cells of the Heart
08:24

Isolation and Identification of Extravascular Immune Cells of the Heart

Published on: August 23, 2018

Área de la Ciencia:

  • Enfermedades infecciosas Enfermedades infecciosas.
  • Cardiología Cardiología.
  • Salud Pública La salud pública.

Sus antecedentes:

  • Incidencia creciente de pericarditis tuberculosa en África, exacerbada por la epidemia del virus de la inmunodeficiencia humana (VIH).
  • La pericarditis tuberculosa plantea un desafío significativo para la salud en las regiones con alta prevalencia del VIH.

Objetivo del estudio:

  • Revisar y sintetizar la literatura actual sobre la patogénesis, el diagnóstico y el manejo de la pericarditis tuberculosa.
  • Proporcionar una visión global de la pericarditis tuberculosa para los médicos e investigadores.

Principales métodos:

  • Búsqueda de la literatura de MEDLINE (1966-2005) y de la Biblioteca Cochrane (2005), donde se encuentran los trabajos realizados.
  • Criterios de diagnóstico definidos para la pericarditis tuberculosa definitiva y probable.
  • Resumió las directrices actuales de tratamiento y las controversias.

Principales resultados:

  • El diagnóstico definitivo requiere la demostración de bacilos tuberculosos; el diagnóstico probable implica hallazgos clínicos y de laboratorio.
  • El tratamiento estándar consiste en un régimen de 6 meses de 4 fármacos antituberculosos.
  • El papel de los corticosteroides adyuvantes es incierto; la pericardiectomía quirúrgica está indicada para la pericarditis constrictiva.

Conclusiones:

  • Es esencial realizar más investigaciones para mejorar la precisión del diagnóstico de la pericarditis tuberculosa.
  • La efectividad de los corticosteroides adyuvantes y el impacto del VIH en los resultados requieren más investigación.
  • Las estrategias de manejo óptimo, particularmente con respecto al calendario de la intervención quirúrgica, necesitan aclaración.